399 related articles for article (PubMed ID: 26681918)
1. Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?
Zhang W; Zhang SL; Hu X; Tam KY
Int J Biol Sci; 2015; 11(12):1390-400. PubMed ID: 26681918
[TBL] [Abstract][Full Text] [Related]
2. Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy.
Anwar S; Shamsi A; Mohammad T; Islam A; Hassan MI
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188568. PubMed ID: 34023419
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs.
Sugden MC; Holness MJ
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E855-62. PubMed ID: 12676647
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer.
Stacpoole PW
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059435
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in pyruvate dehydrogenase kinase inhibitors: Structures, inhibitory mechanisms and biological activities.
Li Y; Xie Z; Lei X; Yang X; Huang S; Yuan W; Deng X; Wang Z; Tang G
Bioorg Chem; 2024 Mar; 144():107160. PubMed ID: 38301426
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Pyruvate Dehydrogenase Kinase as a Therapeutic Strategy against Cancer.
Sradhanjali S; Reddy MM
Curr Top Med Chem; 2018; 18(6):444-453. PubMed ID: 29788890
[TBL] [Abstract][Full Text] [Related]
7. The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents.
Saunier E; Benelli C; Bortoli S
Int J Cancer; 2016 Feb; 138(4):809-17. PubMed ID: 25868605
[TBL] [Abstract][Full Text] [Related]
8. Hormonal regulation of glycolytic enzyme gene and pyruvate dehydrogenase kinase/phosphatase gene transcription.
Wang Z; Iwasaki Y; Zhao LF; Nishiyama M; Taguchi T; Tsugita M; Kambayashi M; Hashimoto K; Terada Y
Endocr J; 2009; 56(8):1019-30. PubMed ID: 19706989
[TBL] [Abstract][Full Text] [Related]
9. Development of pyruvate dehydrogenase kinase inhibitors in medicinal chemistry with particular emphasis as anticancer agents.
Zhang SL; Hu X; Zhang W; Yao H; Tam KY
Drug Discov Today; 2015 Sep; 20(9):1112-9. PubMed ID: 25842042
[TBL] [Abstract][Full Text] [Related]
10. Pyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and Cancers.
Jeoung NH
Diabetes Metab J; 2015 Jun; 39(3):188-97. PubMed ID: 26124988
[TBL] [Abstract][Full Text] [Related]
11. R-lipoic acid inhibits mammalian pyruvate dehydrogenase kinase.
Korotchkina LG; Sidhu S; Patel MS
Free Radic Res; 2004 Oct; 38(10):1083-92. PubMed ID: 15512796
[TBL] [Abstract][Full Text] [Related]
12. Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors.
Zhang W; Hu X; Zhou W; Tam KY
J Proteome Res; 2018 Sep; 17(9):3012-3021. PubMed ID: 30028142
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides as pyruvate dehydrogenase kinase 1 (PDK1) inhibitors to reduce the growth of cancer cells.
Zhang SL; Zhang W; Yang Z; Hu X; Tam KY
Eur J Pharm Sci; 2017 Dec; 110():87-92. PubMed ID: 28347773
[TBL] [Abstract][Full Text] [Related]
14. High-throughput screening of novel pyruvate dehydrogenase kinases inhibitors and biological evaluation of their in vitro and in vivo antiproliferative activity.
Wu DM; Wang YJ; Fan SH; Zhang ZF; Shan Q; Lu J; Chen GQ; Zheng YL
Eur J Med Chem; 2019 Feb; 164():252-262. PubMed ID: 30597326
[TBL] [Abstract][Full Text] [Related]
15. Computational Study on New Natural Compound Inhibitors of Pyruvate Dehydrogenase Kinases.
Zhou X; Yu S; Su J; Sun L
Int J Mol Sci; 2016 Mar; 17(3):340. PubMed ID: 26959013
[TBL] [Abstract][Full Text] [Related]
16. Pyruvate dehydrogenase kinases (PDKs): an overview toward clinical applications.
Wang X; Shen X; Yan Y; Li H
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33739396
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis.
Woolbright BL; Rajendran G; Harris RA; Taylor JA
Mol Cancer Ther; 2019 Oct; 18(10):1673-1681. PubMed ID: 31511353
[TBL] [Abstract][Full Text] [Related]
18. Targeting cellular metabolism to improve cancer therapeutics.
Zhao Y; Butler EB; Tan M
Cell Death Dis; 2013 Mar; 4(3):e532. PubMed ID: 23470539
[TBL] [Abstract][Full Text] [Related]
19. Development of dual inhibitors targeting pyruvate dehydrogenase kinases and human lactate dehydrogenase A: High-throughput virtual screening, synthesis and biological validation.
Xiang S; Huang D; He Q; Li J; Tam KY; Zhang SL; He Y
Eur J Med Chem; 2020 Oct; 203():112579. PubMed ID: 32688200
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel pyruvate dehydrogenase kinases inhibitors by screening of an in-house small molecule library for anti-lung cancer therapeutics.
Guo F; Zhao S; Li X
Bioorg Med Chem Lett; 2019 Jan; 29(2):291-296. PubMed ID: 30470491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
